DoxyPEP and antibiotic resistance: What have we learned so far?
February 17, 2026 • By Sean HoseinStudies have found that the antibiotic doxycycline, when taken after sexual exposure, can significantly reduce the risk of some bacterial sexually transmitted infections like chlamydia and syphilis. However, it is generally less effective at reducing the risk of gonorrhea. Some researchers are concerned that over the long term, widespread use of doxycycline as post-exposure prophylaxis (doxyPEP) may diminish the antibiotic’s effectiveness, or even weaken the efficacy of some other antibiotics. Is this concern realistic? And if so, are the benefits worth the risk? Clinical trials The initial clinical trial of doxyPEP in San Francisco and Seattle found low rates of...
